Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Genet Med. 2013 Apr 4;15(9):721–728. doi: 10.1038/gim.2013.37

Table 1.

Criteria for Stages I & II

Stage I
Criteria Questions
Actionability Is there a practice guideline or systematic review for the genetic condition?
Does the practice guideline or systematic review indicate that the result is actionable in one or more of the following ways: a) patient management, b) surveillance or screening, c) family management, or d) circumstances to avoid?
Is the result actionable in an undiagnosed adult with the genetic condition?
Penetrance Is there at least one known pathogenic variant with at least moderate penetrance (≥40%) or moderate relative risk (≥2) for important health implications in any population?
Significance/Burden of disease Is this condition an important health problem?
Stage II
Criteria Questions
Significance/Burden of disease What is the nature of the threat to health for an individual carrying a deleterious allele?
Disease Incidence Disease Prevalence
Clinical Features (Signs/Symptoms) Natural History
Significance/Burden of Condition
Actionability How effective are available interventions for preventing the harm?
Patient Management Surveillance
Family Management Circumstances to Avoid
Penetrance What is the chance that this threat will materialize?
Prevalence Penetrance
Expressivity Relative Risk
Acceptability of Intervention How acceptable are available interventions in terms of the burdens or risks placed on the individual?
Risks Would the underlying risk or condition escape detection prior to harm in the setting of recommended care?
Chance to escape clinical detection in adults